Renalis treats chronic, expensive and stigmatized conditions below the belt (pelvic health disorders) in females with easy to use, clinically-proven digital therapeutics. By doing so, Renalis solves a void in the market for accessible solutions for first-line therapy for the 33 million+ people struggling with these disorders. Renalis’ novel platform removes barriers to equity and access to treatment; saving providers & patients time, improving outcomes and reducing healthcare costs.